Literature DB >> 24188106

Ceruloplasmin dysfunction: a key factor in the pathophysiology of atrial fibrillation?

J Y Jeremy1, N Shukla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24188106     DOI： 10.1111/joim.12156

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  4 in total

1.  Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study.

Authors:  Antonio P Arenas de Larriva; Alvaro Alonso; Faye L Norby; Nicholas S Roetker; Aaron R Folsom
Journal:  J Thromb Haemost       Date:  2019-03-18       Impact factor: 5.824

2.  Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.

Authors:  Antonio P Arenas de Larriva; Faye L Norby; Lin Y Chen; Elsayed Z Soliman; Ron C Hoogeveen; Dan E Arking; Laura R Loehr; Alvaro Alonso
Journal:  Int J Cardiol       Date:  2017-04-06       Impact factor: 4.164

3.  Serum Ceruloplasmin as a Potential Clinical Biomarker in Atopic Dermatitis.

Authors:  Youin Bae; Seong-Jin Kim
Journal:  Ann Dermatol       Date:  2022-08       Impact factor: 0.722

4.  Ceruloplasmin and Coronary Heart Disease-A Systematic Review.

Authors:  Antonio P Arenas de Larriva; Laura Limia-Pérez; Juan F Alcalá-Díaz; Alvaro Alonso; José López-Miranda; Javier Delgado-Lista
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.